Equities

SkinBioTherapeutics PLC

SkinBioTherapeutics PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)14.00
  • Today's Change-0.625 / -4.27%
  • Shares traded776.79k
  • 1 Year change-41.05%
  • Beta2.5299
Data delayed at least 20 minutes, as of Nov 12 2024 15:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in GBX

The one analyst offering a 12 month price target expects Skinbiotherapeutics PLC share price to rise to 56.00 in the next year from the last price of 14.00.
High300.0%56.00
Med300.0%56.00
Low300.0%56.00

Earnings history & estimates in GBX

Skinbiotherapeutics PLC reported annual 2023 losses of -1.72 per share on Nov 30, 2023.
Average growth rate-29.64%
More ▼

Revenue history & estimates in GBP

SkinBioTherapeutics Plc had revenues for the full year 2023 of 132.00k. This was 76.00% above the prior year's results.
Average growth rate+38.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.